Washington University School of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).

1,502 total trials 214 currently recruiting 919 completed early-phase tilt top decile by trial count

Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.

Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.

Top-decile sponsor footprint

Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 38/100

919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,502 total, page 26 of 31

COMPLETED

Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage

NCT00962546

TERMINATED Phase 1

Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer

NCT00921310

COMPLETED Phase 2

Intravenous (IV) AMD3100 for Mobilization and Matched Related Transplant for Advanced Hematological Malignancies

NCT00914849

COMPLETED Phase 2

Enhanced Medical Rehabilitation for Disablement

NCT00951691

COMPLETED

Exploring Voluntary Control of Tinnitus

NCT00973648

TERMINATED Phase 2

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

NCT00966992

COMPLETED Phase 2

PD4PD:Partnered Dance for Parkinson Disease

NCT01388556

COMPLETED

The Impact of Thumb Carpometacarpal Osteoarthritis on General Health

NCT01133197

COMPLETED

New Data Analysis Methods for Actigraphy in Sleep Medicine

NCT00949858

COMPLETED Early Phase 1

Myocardial Perfusion Magnetic Resonance Imaging Using Regadenoson

NCT00881218

COMPLETED

The Safety of Hand Surgery in the Anticoagulated Patient

NCT00954928

COMPLETED

Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)

NCT00940537

COMPLETED NA

Abscess Packing Versus Wick Placement After Incision and Drainage

NCT01281930

COMPLETED Early Phase 1

Phytosterols, Ezetimibe, and Cholesterol Metabolism

NCT00863265

COMPLETED NA

Early Motion After Volar Fixation for Distal Radius Fractures

NCT00955734

COMPLETED

Pediatric Femur Research Project

NCT00943332

COMPLETED Phase 2

rTMS To The Dorsolateral Prefrontal Cortex For Patients With Subjective Idiopathic Tinnitus. A Pilot Study

NCT00886938

COMPLETED NA

Phosphorous Magnetic Resonance Spectroscopy of Heart

NCT01110395

COMPLETED NA

Optimizing Treatment of Post-hemorrhagic Ventricular Dilation in Preterm Infants

NCT00875758

COMPLETED Phase 1

Erlotinib and Temsirolimus for Solid Tumors

NCT00770263

COMPLETED Phase 4

Methadone in Pediatric Anesthesia

NCT00921843

COMPLETED NA

Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression

NCT00953745

COMPLETED Phase 2

Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma

NCT00802880

COMPLETED Early Phase 1

A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses

NCT00826488

COMPLETED NA

Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia

NCT00901394

COMPLETED Phase 1

Temsirolimus and Radiation for Non-Small Cell Lung Cancer

NCT00796796

COMPLETED NA

Effect of Diet-induced Weight Loss on HIV-associated Metabolic Syndrome

NCT00857298

COMPLETED NA

FDG-PET Imaging in Young Cystic Fibrosis Patients

NCT00846053

COMPLETED Phase 2

CC-4047 (Pomalidomide) for Graft vs. Host Disease

NCT00770757

COMPLETED NA

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

NCT00910988

COMPLETED Phase 4

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

NCT00823303

COMPLETED NA

fMRI Study of Treatment Changes in Major Depression

NCT01027559

TERMINATED NA

Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic Diseases

NCT00840567

TERMINATED NA

Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine

NCT00880594

TERMINATED Phase 1

Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer

NCT00732082

COMPLETED NA

Effect of Resvida, a Comparison With Calorie Restriction Regimen

NCT00823381

COMPLETED

New Non-invasive Methods for Real-time Monitoring of Organ Function.

NCT00851851

COMPLETED Phase 1

Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1

NCT00968656

COMPLETED Phase 1

Oral Clofarabine for Acute Myeloid Leukemia

NCT00727766

TERMINATED

Behavioral Effects of Kuvan in Children With Mild Phenylketonuria

NCT00827762

TERMINATED NA

Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma

NCT00851682

TERMINATED

Feasibility and Functionality of fPAM Imaging in Melanoma

NCT00776945

COMPLETED Phase 2

Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer

NCT00736944

COMPLETED NA

The Effect of an Azygos Vein Coil on Defibrillation Threshold

NCT00798174

COMPLETED Phase 1

Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus

NCT00798915

COMPLETED

Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)

NCT00847431

COMPLETED

Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia

NCT00917280

COMPLETED NA

Impact of Maternal Pomegranate Juice on Brain Injury in Infants With Intrauterine Growth Restriction (IUGR)

NCT00788866

COMPLETED Phase 1

Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma

NCT00733824

COMPLETED NA

A Randomized Controlled Trial of Oral Naproxen and Transdermal Estradiol for Bleeding in LNG-IUC

NCT00789802

← Previous Page 26 of 31 Next →

Phase Distribution

PhaseTrial count
Phase 1 332
Phase 2 237
Phase 3 40
Phase 4 58

What is open in the Washington University School of Medicine pipeline

214 recruiting of 1,502 indexed (14% open); 919 completed (61%).

Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).

Top condition: Obesity (20 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Washington University School of Medicine: open-pipeline peers nationwide

Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 5%10%15%20% Total trials Recruiting share Washington University School of MedicineYale UniversityJohns Hopkins UniversityUniversity of PennsylvaniaNovartis PharmaceuticalsAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAlaska Blind Child Discovery
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,502 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Washington University School of Medicine page

1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.

  • 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.